Skip to main content

Delfa is building the AI-native operatingsystem for clinical operations, startingwith patient recruitment.

There are more than 22,000 drug candidates in the R&D pipeline...

...yet only 5,000 clinical trials are started each year.

Life saving drugs are stuck in a queue. Science isn't the bottleneck, clinical operations are.

Delfa is removing this bottleneck with the only AI-native operating system for clinical operations.

Delfa is building the first AI-native operating system to automate busywork, streamline processes, and turbocharge outcomes. Built specifically for clinical operations. If we succeed, we will significantly increase society's capacity to bring new medicines to market.

Discovery

Mission illustration

Our initial insight came after we experienced the pain felt by coordinators wasting hours and hours of their day calling potential participants.


It then become apparent that busywork is slowing clinical research everywhere.

How it started

Mission illustration
Delfa was founded on the belief that applying state-of-the-art AI to life science operations is the defining challenge of our time.

Today, our world class team delivers cutting-edge AI systems that transform how leading research organizations operate.

Watch us announce our seed round

How it's going

Delfa's AI agents have supported recruitment on 300+ clinical trials. The company has raised over $4,000,000 from investors who have backed ElevenLabs, Profluent and Recursion.

300+
Clinical trials supported.
$4,000,000
Raised in funding from leading venture capitalists.
3
Continents
250,000+
Participants

We're hiring!

Want to make a meaningful impact on clinical research? Join the team in person at our London office.